Radiation therapy for nasopharyngeal carcinoma: histologic appearances and patterns of tumor regression
- PMID: 1612574
- DOI: 10.1016/0046-8177(92)90342-z
Radiation therapy for nasopharyngeal carcinoma: histologic appearances and patterns of tumor regression
Abstract
Nasopharyngeal carcinoma is a common malignancy in Hong Kong and is treated by external radiotherapy. After 6.5 weeks of radiotherapy, the nasopharynx of 100 patients was examined and biopsy specimens were taken. All patients had repeated examination and biopsies done every 2 weeks until exophytic tumor was not seen and biopsy samples were negative on more than one examination of the nasopharynx. The interval between the cessation of therapy and biopsy ranged from 1 day to 11 weeks. Twenty-three patients had atypical findings and five of these had residual tumor requiring gold grain implantation brachytherapy. We identified a number of distinct pathologic changes in the post-biopsy material. Most of these changes disappeared 8 weeks after the cessation of therapy, but the presence of residual tumor after this time was an indication for subsequent therapy. If the date of the first biopsy was delayed until 6 weeks after the completion of radiotherapy, the percentage of atypical biopsies containing residual tumor rose from 21% to 55%. The posttreatment biopsy should be performed twice, as four patients had negative biopsy findings due to sampling error.
Similar articles
-
Nasopharyngeal carcinoma. Pattern of tumor regression after radiotherapy.Cancer. 1990 Jan 15;65(2):216-20. doi: 10.1002/1097-0142(19900115)65:2<216::aid-cncr2820650206>3.0.co;2-z. Cancer. 1990. PMID: 2295044
-
Correlation of endoscopic and histologic findings before and after treatment for nasopharyngeal carcinoma.Head Neck. 2001 Jan;23(1):34-41. Head Neck. 2001. PMID: 11190856
-
Long term results of radioactive gold grain implantation for the treatment of persistent and recurrent nasopharyngeal carcinoma.Cancer. 2001 Mar 15;91(6):1105-13. Cancer. 2001. PMID: 11267955 Clinical Trial.
-
How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?Int J Radiat Oncol Biol Phys. 1998 Mar 1;40(4):897-913. doi: 10.1016/s0360-3016(97)00854-7. Int J Radiat Oncol Biol Phys. 1998. PMID: 9531376 Review.
-
[Carcinoma of the nasopharynx. Clinical aspects, indications and results of external radiotherapy and brachytherapy. State of the art in 2001].Cancer Radiother. 2001 Nov;5 Suppl 1:189s-194s. Cancer Radiother. 2001. PMID: 11797281 Review. French.
Cited by
-
A Nomogram for the Prognosis of Nasopharyngeal Carcinoma with MR Imaging-Detected Tumor Residue at the End of Intensity-Modulated Radiotherapy.Cancer Manag Res. 2020 May 25;12:3835-3844. doi: 10.2147/CMAR.S252047. eCollection 2020. Cancer Manag Res. 2020. PMID: 32547219 Free PMC article.
-
Virus-associated neoplasms of the nasopharynx and sinonasal tract: diagnostic problems.Mod Pathol. 2017 Jan;30(s1):S68-S83. doi: 10.1038/modpathol.2016.189. Mod Pathol. 2017. PMID: 28060369 Review.
-
Prognostication of serial post-intensity-modulated radiation therapy undetectable plasma EBV DNA for nasopharyngeal carcinoma.Oncotarget. 2017 Jan 17;8(3):5292-5308. doi: 10.18632/oncotarget.14137. Oncotarget. 2017. PMID: 28029657 Free PMC article. Clinical Trial.
-
Nasopharyngeal carcinoma in situ in nasopharyngeal carcinoma.J Clin Pathol. 1992 Oct;45(10):898-901. doi: 10.1136/jcp.45.10.898. J Clin Pathol. 1992. PMID: 1430260 Free PMC article.
-
The prognostic significance of race in nasopharyngeal carcinoma by histological subtype.Head Neck. 2021 Jun;43(6):1797-1811. doi: 10.1002/hed.26639. Epub 2021 Feb 23. Head Neck. 2021. PMID: 33620125 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources